MARKET

AEZS

AEZS

Aeterna Zentaris Inc
NASDAQ
4.500
-0.087
-1.90%
Closed 15:46 06/24 EDT
OPEN
4.660
PREV CLOSE
4.587
HIGH
4.840
LOW
4.500
VOLUME
6.88K
TURNOVER
0
52 WEEK HIGH
12.80
52 WEEK LOW
3.960
MARKET CAP
13.78M
P/E (TTM)
-0.3027
1D
5D
1M
3M
1Y
5Y
Weekly Report: what happened at AEZS last week (0617-0621)?
Weekly Report · 16h ago
Weekly Report: what happened at AEZS last week (0610-0614)?
Weekly Report · 06/17 10:49
Aeterna Zentaris Wraps Up Key Pediatric Trial
TipRanks · 06/13 13:42
AETERNA ZENTARIS ANNOUNCES LAST PATIENT LAST VISIT IN PIVOTAL DETECT-TRIAL FOR THE DIAGNOSIS OF CHILDHOOD-ONSET GROWTH HORMONE DEFICIENCY
Reuters · 06/13 13:11
Aeterna Zentaris and Ceapro Announce Merger Completion
TipRanks · 06/10 18:03
Weekly Report: what happened at AEZS last week (0603-0607)?
Weekly Report · 06/10 10:51
*News On Ceapro Inc. (CZO.V) Now Under AEZS.T
Dow Jones · 06/07 21:08
Shareholder Alert: Ademi LLP investigates whether Aeterna Zentaris Inc.'s transaction with Ceapro was Fair to Shareholders
Barchart · 06/07 02:18
More
About AEZS
Aeterna Zentaris Inc. is a Canada-based specialty biopharmaceutical company. The Company is developing and commercializing a diversified portfolio of pharmaceutical and diagnostic products focused on areas of significant unmet medical need. The Company's lead product, macimorelin (Macrilen, Ghryvelin), is an oral test indicated for the diagnosis of adult growth hormone deficiency (AGHD). The Company is also leveraging the clinical and compelling safety profile of macimorelin to develop it for the diagnosis of childhood-onset growth hormone deficiency (CGHD). It is also engaged in the development of therapeutic assets and proprietary extraction technology, which is applied to the production of active ingredients from renewable plant resources, which are used in cosmeceutical products, such as oat beta glucan and avenanthramides, and is being developed as potential nutraceuticals and/or pharmaceuticals. Its therapeutic development pipeline includes AIM Biologicals, AEZS-150 and AEZS-1.

Webull offers AEterna Zentaris Inc. (USA) stock information, including NASDAQ: AEZS real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, AEZS stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading AEZS stock methods without spending real money on the virtual paper trading platform.